Daehwa Pharm. to patent an anti-cancer therapy.

Published: 2005-12-28 07:00:00

Updated: 2005-12-28 07:00:00

Daehwa pharmaceutical company announced on Dec. 22 that the company developed an application method of Paclitaxel, an anti-cancer drug, to the chemical blocking therapy, a sort of liver cancer therapy, which was registered to the Patent Office.

The chemical blocking therapy is a kind of targe...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK